Erectile dysfunction (ED) is inconvenient enough on its own. The last thing you want is a pile-on of other inconveniences, like having to go to a doctor’s office for a diagnosis and prescription — and ...
Introduction: What Even Is Hims & Hers Health? In the pop culture of the investing community, Hims & Hers Health, Inc. (HIMS) (Hims for short) has been described in all manner of ways: The ED pill ...
The company that once focused on discreet issues like hair loss and ED is now leaning into full-spectrum wellness — from nutrient testing to longevity. Dudum says diagnostic capabilities will ...
Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But parts of the company’s forecast came in below estimates, and looming worries about the ...
In this video, I will cover Hims & Hers' (HIMS 1.19%) recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock prices used were ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results